Enugu targets 710,149 more residents for Yellow Fever vaccination

Enugu state government has extended its Yellow Fever vaccination to three local government areas, aimed at targeting additional 710,149 residents.

Executive Secretary of Enugu State Primary Health Care Development Agency (ENS-PHCDA), Dr George Ugwu, disclosed this to newsmen in Enugu on at the weekend.

Ugwu said the new council areas being covered are; Uzo Uwani, Nkanu East and Enugu East.
The executive secretary said the vaccination in these council areas had already begun for 10 days, running from January 9 to 18.
He urged residents within the council areas between the ages of nine months and 44 years to visit Primary Healthcare Centres, other health facilities and special designated places to get vaccinated free-of-charge.


According to him, “so far, we have covered nine council areas and hope that it would soon extend to all council areas in the state to ensure our people are well-protected from the disease.
To really stamp out yellow fever and see that it do not re-cur in the state; we discussed and got approval from our partners, the National Primary Health Care Development Agency, WHO, UNICEF as well as other international and local partners. With their approval and guide, we have started continued massive reactive yellow fever vaccination in three council areas in the state.


We have so far covered nine council areas, where every eligible person that presented themselves at our vaccinating centres has been vaccinated against yellow fever. Apart from the new three council areas; we have done five days catch-up (mop-up) for the initial six council areas covered and enhanced public enlightenment on the benefit and need of the vaccines in order to ensure no single person was left out.


We believe that it will not be long, as we envisage that the entire state will be vaccinated against yellow fever,’’ he said. Ugwu said that for the nine council areas,we have a total target of 2,320,516 residents of the state for the nine council areas.”

Leave a Reply